Exane Derivatives’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $83 | Hold |
6
| – | – | ﹤0.01% | 722 |
|
|
2022
Q1 | $98 | Hold |
6
| – | – | ﹤0.01% | 988 |
|
|
2021
Q4 | $98 | Hold |
6
| – | – | ﹤0.01% | 848 |
|
|
2021
Q3 | $89 | Hold |
6
| – | – | ﹤0.01% | 1007 |
|
|
2021
Q2 | $105 | Hold |
6
| – | – | ﹤0.01% | 1009 |
|
|
2021
Q1 | $138 | Hold |
6
| – | – | ﹤0.01% | 837 |
|
|
2020
Q4 | $148 | Hold |
6
| – | – | ﹤0.01% | 788 |
|
|
2020
Q3 | $249 | Hold |
6
| – | – | ﹤0.01% | 690 |
|
|
2020
Q2 | $287 | Hold |
6
| – | – | ﹤0.01% | 621 |
|
|
2020
Q1 | $378 | Hold |
6
| – | – | ﹤0.01% | 599 |
|
|
2019
Q4 | $677 | Sell |
6
-3,781
| -100% | -$427K | ﹤0.01% | 556 |
|
|
2019
Q3 | $251K | Hold |
3,787
| – | – | 0.05% | 207 |
|
|
2019
Q2 | $301K | Buy |
3,787
+3,781
| +63,017% | +$301K | 0.05% | 210 |
|
|
2019
Q1 | $671 | Hold |
6
| – | – | ﹤0.01% | 499 |
|
|
2018
Q4 | $605 | Sell |
6
-1
| -14% | -$101 | ﹤0.01% | 559 |
|
|
2018
Q3 | $884 | Hold |
7
| – | – | ﹤0.01% | 508 |
|
|
2018
Q2 | $588 | Hold |
7
| – | – | ﹤0.01% | 521 |
|
|
2018
Q1 | $414 | Sell |
7
-943
| -99% | -$55.8K | ﹤0.01% | 491 |
|
|
2017
Q4 | $55.5K | Sell |
950
-4,127
| -81% | -$241K | 0.01% | 298 |
|
|
2017
Q3 | $295K | Buy |
5,077
+5,066
| +46,055% | +$294K | 0.06% | 152 |
|
|
2017
Q2 | $1.33K | Buy |
+11
| New | +$1.33K | ﹤0.01% | 419 |
|